Prediction of response of skeletal metastases from cancer of the prostate to high activity 186Re HEDP therapy.

被引：0
|
作者：
McCready, VR
O'Sullivan, J
Dearnaley, D
Cook, G
机构：
[1] Royal Marsden Hosp, Sutton, Surrey, England
[2] Inst Canc Res, Sutton, Surrey, England
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1272
引用
收藏
页码：316P / 316P
页数：1
相关论文
共 50 条
  • [21] Clinical implications of bone formation and resorption markers after palliative therapies for painful osseous metastases with 186Re-HEDP in prostate cancer patients
    Zafeirakis, A.
    Papatheodorou, G.
    Limouris, G. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S289 - S289
  • [22] Prediction of the correct measured activity of 186Re and 188Re from reactor produced natural rhenium using an artificial neural network
    Leila, Moghaddam B.
    Setayeshi, Saeed
    Maragheh, Mohammad G.
    Gholipour, Reza
    ANNALS OF NUCLEAR ENERGY, 2009, 36 (11-12) : 1676 - 1680
  • [23] SAFETY AND EFFICACY OF REPEATED SEQUENTIAL ADMINISTRATIONS OF RE-186(SN)HEDP AS PALLIATIVE THERAPY FOR PAINFUL SKELETAL METASTASES - INITIAL CASE-REPORTS OF 2 PATIENTS
    ENGLARO, EE
    SCHRODER, LE
    THOMAS, SR
    WILLIAMS, CC
    MAXON, HR
    CLINICAL NUCLEAR MEDICINE, 1992, 17 (01) : 41 - 44
  • [24] The use of 99mTc-MDP bone scans for the estimation of lesion dose in high activity 186Re-HEDP therapy
    Binnie, D
    Divoli, A
    McCready, R
    Flux, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S469 - S469
  • [25] Serum hemoglobin levels predict response to strontium-89 and rhenium-186-HEDP radionuclide treatment for painful osseous metastases in prostate cancer
    van der Poel, H. G.
    Antonini, N.
    Hoefnagel, C. A.
    Horenblas, S.
    Olmos, R. A. Valdes
    UROLOGIA INTERNATIONALIS, 2006, 77 (01) : 50 - 56
  • [26] RE-186/RE-188(SN)HEDP FROM NON-ENRICHED, NATURALLY-OCCURRING TARGETS - A LESS COSTLY PREPARATION FOR TREATMENT OF PAINFUL SKELETAL METASTASES
    WASHBURN, LC
    BINIAKIEWICZ, DS
    EHRHARDT, GJ
    MAXON, HR
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P244 - P244
  • [27] Dosimetry of metastases and whole body in repeated radionuclide therapy of bone metastases from prostate cancer with rhenium-188 HEDP.
    Palmedo, H.
    Bucerius, J.
    Biermann, K.
    Schwarz, B.
    Naeke, C.
    Amadzahdefar, H.
    Schmaljohann, J.
    Guhlke, S.
    Bastian, N.
    Biersack, H. J.
    Reichmann, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S189 - S189
  • [28] A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial)
    van Dodewaard-de Jong, Joyce M.
    de Klerk, John M. H.
    Bloemendal, Haiko J.
    van Bezooijen, Bart P. J.
    de Haas, Marie J.
    Wilson, Richard H.
    O'Sullivan, Joe M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (11) : 1990 - 1998
  • [29] Liver and lymph node metastases of prostate cancer visualized on post-therapy imaging after treatment with 188Re-HEDP
    Khalaf, F.
    Dogan, A. S.
    Haslerud, T.
    Sabet, A.
    Biersack, H. J.
    Ezziddin, S.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2014, 33 (01): : 58 - 59
  • [30] A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial)
    Joyce M. van Dodewaard-de Jong
    John M. H. de Klerk
    Haiko J. Bloemendal
    Bart P. J. van Bezooijen
    Marie J. de Haas
    Richard H. Wilson
    Joe M. O’Sullivan
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1990 - 1998
12345